Your browser doesn't support javascript.
loading
Disitamab vedotin, a novel HER2-directed antibody-drug conjugate in gastric cancer and other solid tumors.
Hu, Yixuan; Zhu, Yinxing; Wei, Xiaowei; Tang, Cuiju; Zhang, Wenwen.
Affiliation
  • Hu Y; Department of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Zhu Y; Department of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
  • Wei X; Department of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China. gswxw@njmu.edu.cn.
  • Tang C; Department of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China. tangcuiju2020@163.com.
  • Zhang W; Department of Oncology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China. wwzhang1022@hotmail.com.
Drugs Today (Barc) ; 58(10): 491-507, 2022 Oct.
Article in En | MEDLINE | ID: mdl-36305543
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Carcinoma, Non-Small-Cell Lung / Immunoconjugates / Lung Neoplasms / Antineoplastic Agents Limits: Humans Language: En Journal: Drugs Today (Barc) Journal subject: MEDICINA OCUPACIONAL / SAUDE AMBIENTAL Year: 2022 Document type: Article Affiliation country: China Country of publication: España
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Stomach Neoplasms / Carcinoma, Non-Small-Cell Lung / Immunoconjugates / Lung Neoplasms / Antineoplastic Agents Limits: Humans Language: En Journal: Drugs Today (Barc) Journal subject: MEDICINA OCUPACIONAL / SAUDE AMBIENTAL Year: 2022 Document type: Article Affiliation country: China Country of publication: España